...
首页> 外文期刊>Scandinavian journal of primary health care. >Randomised, double blind, placebo controlled trial of penicillin V in the treatment of acute maxillary sinusitis in adults in general practice
【24h】

Randomised, double blind, placebo controlled trial of penicillin V in the treatment of acute maxillary sinusitis in adults in general practice

机译:青霉素V治疗成人急性上颌窦炎的随机,双盲,安慰剂对照试验

获取原文
           

摘要

Objective - To compare the effectiveness of penicillin V with placebo in the treatment of adult patients with acute maxillary sinusitis in general practice. Design - Randomised, double blind, placebo controlled trial. Setting - 26 Danish general practices. Patients - 133 adult patients with a clinical diagnosis of acute maxillary sinusitis based on maxillary pain and raised values of either C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR). Main outcome measures - Pain score and illness score as well as measurement of CRP and ESR values after initiation of treatment. Results - Penicillin V led to a better recovery than did placebo. The difference was statistically significant 3 days after the initiation of treatment with regard to pain reduction, whereas no significant difference was found with regard to the reduction in the sense of illness. At the end of the study, significantly more patients in the penicillin group were completely free of pain compared to the placebo group. This difference was only found in patients with an initial pain score of more than three. The cure rate was 71% in the penicillin group and 37% in the placebo group. Significantly more patients achieved normal CRP values when treated with penicillin (88%) as opposed to placebo (75%). Conclusion - Penicillin V is more effective than placebo in the treatment of acute maxillary sinusitis in adults in general practice, but only in patients with pronounced pain.
机译:目的-比较青霉素V和安慰剂在一般实践中对成年急性上颌窦炎患者的治疗效果。设计-随机,双盲,安慰剂对照试验。背景-丹麦的26种常规做法。患者-133名成年患者,根据上颌疼痛和C反应蛋白(CRP)或红细胞沉降率(ESR)升高而临床诊断为急性上颌窦炎。主要结局指标-开始治疗后的疼痛评分和疾病评分以及CRP和ESR值的测量。结果-青霉素V导致的恢复优于安慰剂。在开始治疗后3天,疼痛减轻的差异在统计学上具有统计学意义,而在减轻疾病感方面未发现显着差异。在研究结束时,与安慰剂组相比,青霉素组中明显更多的患者完全没有疼痛。这种差异仅在最初的疼痛评分超过三分的患者中发现。青霉素组治愈率为71%,安慰剂组为37%。与安慰剂(75%)相比,接受青霉素(88%)治疗的患者达到了正常的CRP值。结论-一般情况下,青霉素V比安慰剂在成人急性上颌窦炎的治疗中更有效,但仅在明显疼痛的患者中有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号